AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
Clinical trial NCT06106945 · RECRUITING
Trial details
- NCT number
- NCT06106945
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-05
- Primary completion
- 2027-08-16
- Enrollment
- 226
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.